BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 10370099)

  • 1. N-Terminal deletions of rKv1.4 channels affect the voltage dependence of channel availability.
    Höllerer-Beitz G; Schönherr R; Koenen M; Heinemann SH
    Pflugers Arch; 1999 Jul; 438(2):141-6. PubMed ID: 10370099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cumulative inactivation and the pore domain in the Kv1 channels.
    Shimizu Y; Kubo T; Furukawa Y
    Pflugers Arch; 2002 Mar; 443(5-6):720-30. PubMed ID: 11889569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Separable effects of human Kvbeta1.2 N- and C-termini on inactivation and expression of human Kv1.4.
    Accili EA; Kuryshev YA; Wible BA; Brown AM
    J Physiol; 1998 Oct; 512 ( Pt 2)(Pt 2):325-36. PubMed ID: 9763623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis involved in the blocking effect of antidepressant metergoline on C-type inactivation of Kv1.4 channel.
    Bai HW; Eom S; Yeom HD; Nguyen KVA; Lee J; Sohn SO; Lee JH
    Neuropharmacology; 2019 Mar; 146():65-73. PubMed ID: 30465811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct block by bisindolylmaleimide of rat Kv1.5 expressed in Chinese hamster ovary cells.
    Choi BH; Choi JS; Jeong SW; Hahn SJ; Yoon SH; Jo YH; Kim MS
    J Pharmacol Exp Ther; 2000 May; 293(2):634-40. PubMed ID: 10773038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of n-dodecylguanidine on A-type potassium channels: role of external surface charges in channel gating.
    Yao JA; Saxena NC; Ziai MR; Ling S; Tseng GN
    Mol Pharmacol; 1995 Jul; 48(1):160-71. PubMed ID: 7623770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation and recovery in Kv1.4 K+ channels: lipophilic interactions at the intracellular mouth of the pore.
    Bett GC; Rasmusson RL
    J Physiol; 2004 Apr; 556(Pt 1):109-20. PubMed ID: 14608006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of ginsenoside Rg(3) on human Kv1.4 channel currents without the N-terminal rapid inactivation domain.
    Lee JH; Choi SH; Lee BH; Shin TJ; Pyo MK; Hwang SH; Kim BR; Lee SM; Bae DH; Rhim H; Nah SY
    Biol Pharm Bull; 2009 Apr; 32(4):614-8. PubMed ID: 19336893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for competition between drug binding and Kvbeta 1.3 accessory subunit-induced N-type inactivation of Kv1.5 channels.
    Decher N; Kumar P; Gonzalez T; Renigunta V; Sanguinetti MC
    Mol Pharmacol; 2005 Oct; 68(4):995-1005. PubMed ID: 16024663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different state dependencies of 4-aminopyridine binding to rKv1.4 and rKv4.2: role of the cytoplasmic halves of the fifth and sixth transmembrane segments.
    Tseng GN
    J Pharmacol Exp Ther; 1999 Aug; 290(2):569-77. PubMed ID: 10411564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-type inactivation involves a significant decrease in the intracellular aqueous pore volume of Kv1.4 K+ channels expressed in Xenopus oocytes.
    Jiang X; Bett GC; Li X; Bondarenko VE; Rasmusson RL
    J Physiol; 2003 Jun; 549(Pt 3):683-95. PubMed ID: 12730347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the K+ channel kv1.4 by acidosis: protonation of an extracellular histidine slows the recovery from N-type inactivation.
    Claydon TW; Boyett MR; Sivaprasadarao A; Ishii K; Owen JM; O'Beirne HA; Leach R; Komukai K; Orchard CH
    J Physiol; 2000 Jul; 526 Pt 2(Pt 2):253-64. PubMed ID: 10896716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NH2-terminal inactivation peptide binding to C-type-inactivated Kv channels.
    Kurata HT; Wang Z; Fedida D
    J Gen Physiol; 2004 May; 123(5):505-20. PubMed ID: 15078918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trafficking of Kv1.4 potassium channels: interdependence of a pore region determinant and a cytoplasmic C-terminal VXXSL determinant in regulating cell-surface trafficking.
    Zhu J; Watanabe I; Gomez B; Thornhill WB
    Biochem J; 2003 Nov; 375(Pt 3):761-8. PubMed ID: 12901718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of (-)-epigallocatechin-3-gallate, the main component of green tea, on the cloned rat brain Kv1.5 potassium channels.
    Choi BH; Choi JS; Min DS; Yoon SH; Rhie DJ; Jo YH; Kim MS; Hahn SJ
    Biochem Pharmacol; 2001 Sep; 62(5):527-35. PubMed ID: 11585049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential sensitivity of voltage-gated potassium channels Kv1.5 and Kv1.2 to acidic pH and molecular identification of pH sensor.
    Steidl JV; Yool AJ
    Mol Pharmacol; 1999 May; 55(5):812-20. PubMed ID: 10220559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-type inactivation in the mammalian Shaker K+ channel Kv1.4.
    Lee TE; Philipson LH; Nelson DJ
    J Membr Biol; 1996 Jun; 151(3):225-35. PubMed ID: 8661510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective agent riluzole dramatically slows inactivation of Kv1.4 potassium channels by a voltage-dependent oxidative mechanism.
    Xu L; Enyeart JA; Enyeart JJ
    J Pharmacol Exp Ther; 2001 Oct; 299(1):227-37. PubMed ID: 11561084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of voltage sensitivity by N-terminal cytoplasmic residues in human Kv1.2 channels.
    Varshney A; S K; Mathew MK
    Eur Biophys J; 2002 Sep; 31(5):365-72. PubMed ID: 12202912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N type rapid inactivation in human Kv1.4 channels: functional role of a putative C-terminal helix.
    Sankaranarayanan K; Varshney A; Mathew MK
    Mol Membr Biol; 2005; 22(5):389-400. PubMed ID: 16308273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.